Driver Response to Hydrogen Fuel Cell Buses in a Real-World Setting Study of a Northern California Transit Bus Fleet

被引:7
|
作者
Lipman, Timothy E. [1 ]
Gray-Stewart, Ananda L. [1 ]
Lidicker, Jeffrey [2 ]
机构
[1] Univ Calif Berkeley, Transportat Sustainabil Res Ctr, Berkeley, CA 94704 USA
[2] Michigan Technol Univ, Dept Civil & Environm Engn, Houghton, MI 49931 USA
关键词
Fuel economy;
D O I
10.3141/2502-06
中图分类号
TU [建筑科学];
学科分类号
0813 ;
摘要
This study examined bus drivers' acceptance of fuel cell electric buses in Alameda-Contra Costa Transit in the San Francisco Bay Area of California. Of the 145 surveys issued, 47 drivers completed a written survey, for a 32% response rate. The study focused on a key attribute for potential success of alternative urban bus technology: the driver acceptance factor. Technology performance flaws that are undesirable or annoying to the bus drivers may also be disruptive to passengers. Furthermore, because of using the buses throughout their full duty cycle, drivers are in a unique position to identify key opportunities to improve the new technology options as they emerge and evolve. The study found that drivers, in general, rated the hydrogen fuel cell buses to be at the same or better performance than diesel buses for handling, ride quality, acceleration, and braking. For quiet operation, the drivers rated the new buses as excellent. When asked how they liked the experimental hydrogen fuel cell buses, drivers responded at just above neutral, with the most common response being "the same" as diesel buses followed by "much better." Those drivers who said that they considered fuel economy when purchasing a vehicle liked the fuel cell buses more. Older drivers preferred the diesel buses, and male drivers preferred the new fuel cell buses. Perceptions of safety were mixed, with some drivers expressing safety concerns independent of how much training they had received.
引用
下载
收藏
页码:48 / 52
页数:5
相关论文
共 50 条
  • [21] CemiplimAb-rwlc survivorship and epidemiology (CASE): A prospective study of safety and efficacy of cemiplimab in patients with advanced basal cell carcinoma in a real-world setting
    Park, Soo J.
    Ellison, David
    Weight, Ryan Michael
    Homsi, Jade
    Rabinowits, Guilherme
    Ruiz, Emily S.
    Strasswimmer, John
    Simmons, Josh David
    Panella, Timothy J.
    Quek, Ruben G. W.
    Ursino, Gregory
    Pouliot, Jean-Francois
    Khushalani, Nikhil I.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [22] Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation: A Cohort Study in the Real-World Setting of a Tertiary Center
    Goker, Hakan
    Cinar, Olgu Erkin
    Demiroglu, Haluk
    Malkan, Uemit Yavuz
    Karakulak, Elifcan Aladag
    Buyukasik, Yahya
    TURKISH JOURNAL OF HEMATOLOGY, 2023, 40 (03) : 213 - 215
  • [23] A multidisciplinary non-invasive approach to monitor response to intravenous immunoglobulin treatment in neurodegenerative Langerhans cell histiocytosis: a real-world study
    Trambusti, Irene
    Barba, Carmen
    Mortilla, Marzia
    Rizzi, Susanna
    Romano, Katiuscia
    Coniglio, Maria Luisa
    Lucenteforte, Ersilia
    Tondo, Annalisa
    Guerrini, Renzo
    Sieni, Elena
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [24] Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: The IMMINENT study
    Sposito, Marco
    Belluomini, Lorenzo
    Insolda, Jessica
    Dodi, Alessandra
    Aprile, Giuseppe
    Veccia, Antonello
    Caffo, Orazio
    Parra, Hector Jose Soto
    Lombardo, Fiorella
    Lugini, Antonio
    Occhipinti, Mario
    Ferrau, Francesco
    Savastano, Clementina
    Verderame, Francesco
    Bria, Emilio
    Novello, Silvia
    Malapelle, Umberto
    Pilotto, Sara
    Milella, Michele
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [25] Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer in the Real-World Setting in Central Europe The INSIGHT Study
    Ramlau, Rodryg
    Cufer, Tanja
    Berzinec, Peter
    Dziadziuszko, Rafal
    Olszewski, Wlodzimierz
    Popper, Helmut
    Bajcic, Paolo
    Dusek, Ladislav
    Zbozinkova, Zuzana
    Pirker, Robert
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : 1370 - 1374
  • [26] Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study
    Sposito, Marco
    Belluomini, Lorenzo
    Nocini, Riccardo
    Insolda, Jessica
    Scaglione, Ilaria Mariangela
    Menis, Jessica
    Simbolo, Michele
    Lugini, Antonio
    Buzzacchino, Federica
    Verderame, Francesco
    Spinnato, Francesca
    Aprile, Giuseppe
    Calvetti, Lorenzo
    Occhipinti, Mario
    Marinelli, Daniele
    Veccia, Antonello
    Lombardo, Fiorella
    Parra, Hector Jose Soto
    Ferrau, Francesco
    Savastano, Clementina
    Porta, Camilla
    Pradelli, Lorenzo
    Sicari, Emilia
    Castellani, Silvia
    Malapelle, Umberto
    Novello, Silvia
    Bria, Emilio
    Pilotto, Sara
    Milella, Michele
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [27] Pragmatic phase II clinical trial to improve depression care in a real-world diverse MS cohort from an academic MS centre in Northern California: MS CATCH study protocol
    Henderson, Kyra
    Reihm, Jennifer
    Koshal, Kanishka
    Wijangco, Jaeleene
    Miller, Nicolette
    Sara, Narender
    Doyle, Marianne
    Mallory, Alicia
    Sheridan, Judith
    Guo, Chu-Yueh
    Oommen, Lauren
    Feinstein, Anthony
    Mangurian, Christina
    Lazar, Ann
    Bove, Riley
    BMJ OPEN, 2024, 14 (02):
  • [28] Prediction of pathologic complete response prediction in patients with locally advanced esophageal squamous cell carcinoma treated with neoadjuvant immunochemotherapy: A real-world study
    Feng, Jifeng
    Wang, Liang
    Yang, Xun
    Chen, Qixun
    Cheng, Xiangdong
    BIOMOLECULES AND BIOMEDICINE, 2023, 23 (01): : 153 - 160
  • [29] Impact of Chronic Gvhd Severity And Steroid Response on The Quality of Life In Patients Following Allogeneic Stem Cell Transplantation: Findings From A Real-World Study
    Lachance, Sylvie
    Hamad, Nada
    de Courcy, Jonathan
    Gibson, Gregor
    Zuurman, Mike
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 83 - 84
  • [30] Insulin tolerance test predicts non response vs. sustained efficacy of Liraglutide on glycemic control in type 2 diabetes patients: A prospective real-world setting study
    Germain, Natacha
    Khalfallah, Yadh
    Estour, Bruno
    Galusca, Bogdan
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 137 : 20 - 27